Liabilities and Equity in USD of Structure Therapeutics Inc. from Q4 2022 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary: Structure Therapeutics Inc. quarterly Liabilities and Equity history and growth rate from Q4 2022 to Q3 2025.
Structure Therapeutics Inc. Liabilities and Equity for the quarter ending September 30, 2025 was $832M, a 10.8% decline year-over-year.

Liabilities and Equity, Quarterly (USD)

Liabilities and Equity, YoY Quarterly Growth (%)

Structure Therapeutics Inc. Quarterly Liabilities and Equity (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$832M	-$101M	-10.8%	Sep 30, 2025	10-Q	2025-11-06
Q2 2025	$816M	-$131M	-13.8%	Jun 30, 2025	10-Q	2025-08-06
Q1 2025	$867M	+$409M	+89.5%	Mar 31, 2025	10-Q	2025-05-08
Q4 2024	$903M	+$421M	+87.4%	Dec 31, 2024	10-Q	2025-11-06
Q3 2024	$933M	+$717M	+331%	Sep 30, 2024	10-Q	2024-11-13
Q2 2024	$947M	+$718M	+313%	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$457M	+$210M	+84.8%	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$482M	+$384M	+393%	Dec 31, 2023	10-K	2025-02-27
Q3 2023	$216M			Sep 30, 2023	10-Q	2023-11-17
Q2 2023	$229M			Jun 30, 2023	10-Q/A	2023-11-17
Q1 2023	$247M			Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$97.8M			Dec 31, 2022	10-K	2024-03-08

* An asterisk sign (*) next to the value indicates that the value is likely invalid.